Skip to main content
. Author manuscript; available in PMC: 2011 Sep 12.
Published in final edited form as: Gastroenterology. 2007 Sep 14;133(6):1806–1813. doi: 10.1053/j.gastro.2007.09.004

Figure 3. Cumulative risk of death after initial living donor evaluation for patients receiving LDLT versus not receiving LDLT.

Figure 3

Risk of death following LDLT diverges beginning at median time of LDLT following donor evaluation (1.8 months) (green line). Estimates are adjusted for age, MELD score, and HCC status, and apply to a patient with age=50, MELD=15, and no HCC.